Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

438
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
438
Analgesia and Pain Management01:25

Analgesia and Pain Management

811
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
811
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

373
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
373
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.9K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

332
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
332
Nociception01:44

Nociception

29.5K
Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
29.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical analgesics for neuropathic pain: an evidence-informed guide for the practicing clinician.

Pain medicine (Malden, Mass.)·2025
Same author

Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement.

Endocrine reviews·2024
Same author

Buprenorphine: The Opioid that Cried 'Partial Agonist'.

Journal of opioid management·2024
Same author

Opioids and Immunosuppression: Clinical Evidence, Mechanisms of Action, and Potential Therapies.

Palliative medicine reports·2024
Same author

Misinterpretation of the "Overdose Crisis" Continues to Fuel Misunderstanding of the Role of Prescription Opioids.

Journal of pain research·2022
Same author

A Survey on Opioid Tapering Practices, Policies, and Perspectives by Pain and Palliative Care Pharmacists.

Journal of pain & palliative care pharmacotherapy·2022

Related Experiment Video

Updated: Sep 15, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.5K

Exploring Beyond Mu: Nonopioid Analgesics.

Brittany A Henault1, Katrina M Dean2, Jeffrey J Bettinger3

  • 1Department of Pharmacy, Wilkes Barre VA Medical Center Pharmacy Department, 1111 East End Blvd, Wilkes Barre, PA 18711, USA.

Neurologic Clinics
|July 17, 2025
PubMed
Summary
This summary is machine-generated.

Chronic pain affects over 20% of US adults, making nonopioid analgesics crucial first-line treatments. Understanding analgesic pharmacology, including interactions and metabolism, is vital for effective pain management.

Keywords:
First-line therapiesMusculoskeletal painNeuropathic painNonopioid analgesicsPain pharmacology

More Related Videos

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.4K
Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

1.8K

Related Experiment Videos

Last Updated: Sep 15, 2025

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
07:23

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities

Published on: July 29, 2014

33.5K
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
07:09

The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice

Published on: July 16, 2014

48.4K
Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
06:54

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

Published on: November 15, 2024

1.8K

Area of Science:

  • Pain Management
  • Pharmacology
  • Public Health

Background:

  • Chronic pain is a significant public health issue, affecting 20.6% of the US population.
  • Opioid prescribing guidelines have evolved, emphasizing nonopioid analgesics.
  • Effective pain management requires a deep understanding of analgesic pharmacology.

Purpose of the Study:

  • To highlight the importance of nonopioid analgesics in chronic pain management.
  • To underscore the need for healthcare providers to understand analgesic pharmacology.
  • To emphasize the consideration of drug-drug interactions, drug-comorbidity interactions, contraindications, and metabolism.

Main Methods:

  • Literature review of current pain management guidelines and pharmacological principles.
  • Analysis of the role of nonopioid analgesics in chronic pain.
  • Examination of key pharmacological considerations for providers.

Main Results:

  • Nonopioid analgesics are consistently recommended as first-line treatments for chronic pain.
  • A comprehensive understanding of analgesic pharmacology is essential for patient-centered care.
  • Key considerations include drug interactions, comorbidities, contraindications, and cytochrome P450 metabolism.

Conclusions:

  • Healthcare providers must prioritize nonopioid analgesics and possess strong pharmacological knowledge.
  • Patient-centered pain management necessitates careful consideration of potential drug interactions and metabolic pathways.
  • Further education on analgesic pharmacology is crucial for optimizing chronic pain treatment.